Association of Clinical Trial Participation With Improved Overall Survival for Recurrent, Platinum-Resistant Ovarian Cancer

Ming Yao,Julia Chalif,Erika J. Lampert,Danielle Chau,Peter G. Rose,Robert Debernardo,Chad M. Michener,Roberto Vargas, Laura M. Chambers

Obstetrical & Gynecological Survey（2023）

引用 0|浏览7

暂无评分

摘要

(Abstracted from Obstet Gynecol 2023;1(00):00) Despite recent advancements in treatment, ovarian cancer remains the leading cause of gynecologic cancer death in the United States. Advanced ovarian cancer is treated using surgery and platinum-based chemotherapy but ultimately recurs in most patients and becomes resistant to platinum chemotherapy.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要